4.6 Article

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases

Related references

Note: Only part of the references are listed.
Article Pathology

Loss of BRG1 (SMARCA4) Immunoexpression in a Pediatric Non-Central Nervous System Tumor Cohort

Jessica Saunders et al.

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2020)

Article Biochemistry & Molecular Biology

ClinVar: improvements to accessing data

Melissa J. Landrum et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Oncology

Translational genomics of malignant rhabdoid tumours: Current impact and future possibilities

Martina A. Finetti et al.

SEMINARS IN CANCER BIOLOGY (2020)

Article Pharmacology & Pharmacy

Ephrin or not? Six tough questions on Eph targeting

Carmine Giorgio et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2020)

Article Biochemical Research Methods

VarSome: the human genomic variant search engine

Christos Kopanos et al.

BIOINFORMATICS (2019)

Review Biochemistry & Molecular Biology

Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis

Till Holsten et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2018)

Article Multidisciplinary Sciences

DNA methylation-based classification of central nervous system tumours

David Capper et al.

NATURE (2018)

Article Biochemical Research Methods

Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi

Jean-Philippe Fortin et al.

BIOINFORMATICS (2017)

Article Multidisciplinary Sciences

The whole-genome landscape of medulloblastoma subtypes

Paul A. Northcott et al.

NATURE (2017)

Review Genetics & Heredity

DNA Methylation, Nuclear Organization, and Cancer

Bhavani P. Madakashira et al.

FRONTIERS IN GENETICS (2017)

Letter Hematology

Global hypomethylation in myeloma is associated with poor prognosis

Jonathan I. Sive et al.

BRITISH JOURNAL OF HAEMATOLOGY (2016)

Letter Oncology

SMARCA4-Mutated Atypical Teratoid/Rhabdoid Tumor with Retained BRG1 Expression

Julien Masliah-Planchon et al.

PEDIATRIC BLOOD & CANCER (2016)

Article Biochemical Research Methods

Analyzing and interpreting genome data at the network level with ConsensusPathDB

Ralf Herwig et al.

NATURE PROTOCOLS (2016)

Article Multidisciplinary Sciences

The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation

Zhi-Yan Han et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

DNA Methylation in the Malignant Transformation of Meningiomas

Fan Gao et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations

Trevor J. Pugh et al.

NATURE (2012)

Article Multidisciplinary Sciences

Novel mutations target distinct subgroups of medulloblastoma

Giles Robinson et al.

NATURE (2012)

Article Multidisciplinary Sciences

Dissecting the genomic complexity underlying medulloblastoma

David T. W. Jones et al.

NATURE (2012)

Review Oncology

Role of Eph/ephrin tyrosine kinase in malignant glioma

Mitsutoshi Nakada et al.

NEURO-ONCOLOGY (2011)

Editorial Material Oncology

Spectrum of SMARCB1/INI1 Mutations in Familial and Sporadic Rhabdoid Tumors

Katherine W. Eaton et al.

PEDIATRIC BLOOD & CANCER (2011)

Article Genetics & Heredity

Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome

Reinhard Schneppenheim et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2010)